Publications by authors named "Frederic Bouder"

Claim this Profile
S
Satisfaction With Governmental Risk Communication Both Increases and Decreases COVID-19 Mitigation Behaviours.
Darrick Evensen, George Warren, Frederic Bouder

Int J Public Health· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relationship Between Barriers and Drivers of COVID-19 Protective Behaviors in Germany and the UK.
Farnaz Mahdavian, George W Warren, Darrick Evensen, Frederic E Bouder

Int J Public Health· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.
Dominic Way, Hortense Blazsin, Ragnar Löfstedt, Frederic Bouder

Drug Saf· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk communication of vaccines: challenges in the post-trust environment.
Frederic Bouder

Curr Drug Saf· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transparency in Europe: A Quantitative Study.
Frederic Bouder, Dominic Way, Ragnar Löfstedt, Darrick Evensen

Risk Anal· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transparency and the Food and Drug Administration--a quantitative study.
Ragnar Lofstedt, Frederic Bouder, Sweta Chakraborty

J Health Commun· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of risk communication and the role of the pharmaceutical industry.
Sweta Chakraborty, Frederic Bouder

Curr Drug Saf· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritizing polio.
Barbara Rath, Mohammad Ali, Chris Elemuwa, Wolfgang Maurer, Frederic Bouder

Expert Rev Vaccines· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of risk approach and the management of pharmaceutical risks.
Frederic Bouder, Ragnar Löfstedt

Expert Rev Clin Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulating impurities in pharmaceutical products: a tolerability of risk approach?
Frederic Bouder

Expert Rev Clin Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis